Prevalence of the common NCD risk factors by Urbanicity. by Ronald Kusolo (13200268)

Subjects:

Participant characteristics. by Ronald Kusolo (13200268)

Subjects:

Medication Use Status of ASD Participants (n = 17). by Tomoe Hayakawa (20978784)

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Participant characteristics (<i>n</i> = 34). by Yong-Rae Kim (19797278)

Subjects:

The images of erosion control dams (ECDs) with three different exteriors. by Yong-Rae Kim (19797278)

Subjects:

Mean amplitude of the Slow Delta Envelope and period of Slow Delta oscillations in the disconnected hemisphere, compared with respect to wakefulness and NREM sleep in the reference... by Michele Angelo Colombo (22446342)

Experimental procedure performed in this study. by Yong-Rae Kim (19797278)

Subjects:

S3 Table - by Yong-Rae Kim (19797278)

Subjects:

S5 Table - by Yong-Rae Kim (19797278)

Subjects:

S1 Table - by Yong-Rae Kim (19797278)

Subjects:

S2 Table - by Yong-Rae Kim (19797278)

Subjects: